Abstract:
The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
Abstract:
A tire with radial carcass reinforcement having beads with a heel portion on an axially inner side and a toe portion on an axially outer side includes two carcass reinforcement plies for tension in higher sidewall tires. The bead includes at least one bead wire coated with a rubber mix, a wedge formed of a rubber mix disposed axially outward of the at least one bead wire, and at least one rubber filler located axially and radially outward of the bead wire and wedge. The wedge is defined by two sides extending at an acute angle axially from an apex A located beneath the section of the at least one bead wire, the rubber mix forming the wedge having a Shore A hardness of at least 65 and greater than the Shore A hardness of the at least one rubber filler. According to one embodiment, a carcass reinforcement includes two plies, a first radial reinforcement ply wound on the at least one bead wire to form a first upturn, as viewed in meridian section, the reinforcement ply is wound about said bead wire passing from the heel to the toe of said at least one bead, the first upturn engaging the radially outer side the wedge and, a second radial reinforcement ply wound on said at least one bead wire, wherein, when viewed in meridian section, the second reinforcement ply is disposed in parallel to the first radial reinforcement ply in a sidewall area of the tire and is wound about said bead wire passing from the heel to the toe of said at least one bead with a second upturn extending into engagement with the radial inner side of the wedge.
Abstract:
The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
Abstract:
The disclosure relates to compounds of formula (I): wherein A, Z, Z′, L, R2 and R3 are as defined in the disclosure, to compositions comprising said compounds, and to methods for the manufacture and therapeutic use thereof.
Abstract:
The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
Abstract:
The disclosure relates to 2-amido-4-phenylthiazole derivatives of general formula (I) below: in which R1, R2, R3, Y, m, n, and p are as defined in the disclosure; as well as to their isomers, salts and solvates, to the pharmaceutical compositions containing them and to the therapeutic use thereof.
Abstract:
The disclosure relates to 2-carbamide-4-phenylthiazole derivatives having the following general formula (I): wherein R1, R2, R3, Y and p are as defined in the disclosure. The disclosure also relates to pharmaceutical compositions containing a compound of formula (I), to processes for preparing the compounds of formula (I), and to methods of using the compounds of formula (I).
Abstract:
The disclosure concerns 2-carbamide-4-phenylthiazole derivatives of general formula (I). The disclosure also concerns pharmaceutical compositions containing a compound of general formula (I) and to processes for preparing and methods of using compounds of general formula (I).
Abstract:
The invention relates to 2-acylamino-4-phenylthiazole derivatives of general formula (I): pharmaceutically acceptable acid-addition salts thereof, hydrates or solvates of such derivatives or such pharmaceutically acceptable acid addition salts, intermediates thereto, processes for the preparation thereof, and therapeutic application thereof.
Abstract:
The disclosure concerns 2-carbamide-4-phenylthiazole derivatives of general formula (I). The disclosure also concerns pharmaceutical compositions containing a compound of general formula (I) and to processes for preparing and methods of using compounds of general formula (I).